Haemonetics (HAE) Deferred Taxes (2015 - 2026)

Haemonetics' Deferred Taxes history runs 12 years deep, the most recent figure standing at -$20.5 million for Q1 2026.

• On a quarterly basis, Deferred Taxes fell 706.19% year-over-year to -$20.5 million in Q1 2026; TTM through Mar 2026 was -$26.5 million, a 407.2% decrease from a year earlier, with the FY2026 full-year figure at -$26.5 million, down 407.2% from the prior year.
• Deferred Taxes fell to -$20.5 million in Q1 2026 per HAE's latest filing, from -$2.1 million in the prior quarter.
• Across five years, Deferred Taxes topped out at $3.4 million in Q1 2025 and bottomed at -$20.5 million in Q1 2026.
• The 5-year median for Deferred Taxes is -$2.4 million (2024), against an average of -$3.1 million.
• Across the five-year window, Deferred Taxes soared 219.41% in 2022 and plunged 706.19% in 2026, its largest moves.
• Year by year, Deferred Taxes stood at $3.0 million in 2022, then plunged by 207.66% to -$3.2 million in 2023, then advanced by 25.52% to -$2.4 million in 2024, then advanced by 14.69% to -$2.1 million in 2025, then plunged by 891.9% to -$20.5 million in 2026.
• Per Business Quant, the three latest HAE Deferred Taxes figures stand at -$20.5 million (Q1 2026), -$2.1 million (Q4 2025), and -$725000.0 (Q3 2025).